4//SEC Filing
Boston Megan 4
Accession 0001062993-24-005969
CIK 0001808898other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 4:12 PM ET
Size
5.1 KB
Accession
0001062993-24-005969
Insider Transaction Report
Form 4
Boston Megan
DirectorChief Financial Officer
Transactions
- Award
Options (right to buy)
2024-03-06+200,004→ 200,004 totalExercise: $5.21Exp: 2034-03-06→ Common Stock (200,004 underlying)
Footnotes (1)
- [F1]The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.
Issuer
Benitec Biopharma Inc.
CIK 0001808898
Entity typeother
Related Parties
1- filerCIK 0001808923
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 4:12 PM ET
- Size
- 5.1 KB